
OPTIMAS
@optimas_ucl
OPtimal TIMing of Anticoagulation after acute ischaemic Stroke: a randomised controlled trial
Clinical trial sponsored by @TheBHF
ID: 1272531237211639811
http://optimas.org.uk 15-06-2020 14:07:54
551 Tweet
438 Followers
424 Following

An article from trial funder British Heart Foundation about our recently published results! bhf.org.uk/what-we-do/new…

Happy to share our editorial in The Lancet on the OPTIMAS trial, exploring early anticoagulation in ischemic #Stroke patients with #AtrialFibrillation. Important findings for improving secondary stroke prevention and patient outcomes Else C. Sandset 👉thelancet.com/journals/lance…




People with atrial fibrillation who have a stroke could benefit from blood thinning treatments at an earlier stage than is currently recommended, finds a new study led by Prof. David Werring (UCL Stroke Research, UCL Queen Square Institute of Neurology). bit.ly/4fdLyik


People with #AFib who have a #Stroke could benefit from receiving DOACs at an earlier stage than is currently recommended, as per a new study led by UCL researchers as well as other findings presented recently at #WSC2024 World Stroke Org Signild Åsberg cardiacrhythmnews.com/transformative…

Meet the experts speaking next week at our 'Highlights from the World Stroke Org 2024' webinar, organized jointly with the European Stroke Org👇 🕐Wednesday, 20th of November, 5-6pm (CET) Not registered yet? Head here: us02web.zoom.us/webinar/regist… #StrokeEducation #Neurology #WSC2024



WSO & ESO joint webinar on uncovering key insights from the World Stroke Congress 2024. 📑 ow.ly/oZNn50U4rtv 📅 20 November 2024,17:00 CET Luciano Sposato 🇦🇷🇨🇦, Signild Åsberg, Urs Martin Fischer Jeyaraj Pandian & Simona Sacco #stroke #neurology #stroketwitter World Stroke Org







Our very own Prof Werring presenting the OPTIMAS results at the UK Stroke Forum UCL Stroke Research -It was also great to witness the OPTIMAS team celebrating the success of the recruiting sites at yesterday's investigator meeting. What a fantastic way of acknowledging the team!


Thanks to the International Journal of Stroke for a great summary of OPTIMAS The Lancet UCL Queen Square Institute of Neurology UCLH and CATALYST results and their implications for #anticoagulation timing in people with acute #stroke and #Afib in clinical practice…


What are the 10 most common pitfalls in non-inferiority trials? Check our latest article in Stroke! Johannes Kaesmacher Stroke Research Center Bern Kilian Treurniet Manon Kappelhof ahajournals.org/doi/10.1161/ST…